Search Results - "Zepp, F."

Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life by Huang, X., Tsilochristou, O., Perna, S., Hofmaier, S., Cappella, A., Bauer, C.‐P., Hoffman, U., Forster, J., Zepp, F., Schuster, A., D'Amelio, R., Wahn, U., Keil, T., Lau, S., Matricardi, P. M.

“…Background In early childhood, the allergen‐specific IgG repertoire is mainly directed to animal and vegetable food molecules and infrequently to airborne…”
Get full text

General principles of vaccination under immunosuppression by Schreiner, D, Zepp, F

“…The number of patients suffering from immunodeficiency is increasing; however, the vaccination rate of these patients is below average. Administration of…”
Get full text

Fever by Zepp, F

Get full text

Associations of preterm birth and neonatal stress exposure with chronic pain in adulthood – Results from the Gutenberg prematurity study by Tesarz, J., Schuster, A.K., Hermes, M., Mildenberger, E., Urschitz, M.S., Treede, R.D., Tost, H., Ernst, M., Beutel, M., Stoffelns, B., Zepp, F., Pfeiffer, N., Fieß, A.

“…Although the effect of early childhood stress on central nervous pain processing is well known, studies on the association of prematurity and chronic pain are…”
Get full text

Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine: Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute by Siedler, A., Koch, J., Garbe, E., Hengel, H., von Kries, R., Ledig, T., Mertens, T., Zepp, F., Überla, K.

Get full text

The best interest of the child (and the adolescent) must be the guiding principle by Zepp, F, Knuf, M

Get full text

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants by Vesikari, T, Karvonen, A, Korhonen, T, Espo, M, Lebacq, E, Forster, J, Zepp, F, Delem, A, De Vos, B

“…A live attenuated human rotavirus (HRV) vaccine, strain RIX4414, was tested sequentially in adults, previously infected toddlers, and previously uninfected…”
Get full text

Pediatric psychology by Fegert, J M, Zepp, F, Kerbl, R

Get full text

Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life by Guiso, N, Njamkepo, E, Vié le Sage, F, Zepp, F, Meyer, C.U, Abitbol, V, Clyti, N, Chevallier, S

“…Abstract Humoral and cell-mediated immune responses (CMI) were evaluated in subjects 3 and 6 years after primary and booster vaccination with either…”
Get full text

Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany by Falkenhorst, G., Harder, T., Remschmidt, C., Terhardt, M., Zepp, F., Ledig, T., Wicker, S., Keller-Stanislawski, B., Mertens, T.

“…The German Standing Committee on Vaccination (STIKO) recommends seasonal influenza vaccination for children and adolescents with chronic medical conditions…”
Get full text

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration by Campins-Martı́, M., Cheng, H.K., Forsyth, K., Guiso, N., Halperin, S., Huang, L.-M., Mertsola, J., Oselka, G., Ward, J., Wirsing von König, C.H., Zepp, F.

“…Pertussis vaccination of infants has dramatically reduced disease, complications and deaths in infancy and early childhood. But there is still a major public…”
Get full text

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants by Zepp, F, Knuf, M, Heininger, U, Jahn, K, Collard, A, Habermehl, P, Schuerman, L, Sänger, R

“…Safety, reactogenicity and immunogenicity of GSK Biologicals’ hexavalent DTPa–HBV–IPV/Hib vaccine (Infanrix ®hexa) was assessed when used for primary…”
Get full text

Atopic dermatitis in early infancy predicts allergic airway disease at 5 years by BERGMANN, R. L, EDENHARTER, G, BERGMANN, K. E, FORSTER, J, BAUER, C. P, WAHN, V, ZEPP, F, WAHN, U

“…Background Screening tests for atopy risk in newborns have a low predictive value. If early atopic symptoms and signs could be used as predictors for the next…”
Get full text

Fieber by Zepp, F.

Get full text

Predictability of early atopy by cord blood-IgE and parental history by BERGMANN, R. L., EDENHARTER, G., BERGMANN, K. E., GUGGENMOOS-HOLZMANN, I., EORSTER, J., BAUERl, C. P., WAHN, V., ZEPP, F., WAHN, U.

“…Summary Background Atopic family history and cord blood IgE have been used as predictors of atopic disease in newborns for about 20 years, but at least for…”
Get full text

The Value of New Adjuvant Technology by Zepp, F, Garçon, N

Get full text

Cell mediated and antibody immune response to inactivated hepatitis A vaccine by Schmidtke, P., Habermehl, P., Knuf, M., Meyer, C.U., Sänger, R., Zepp, F.

“…The humoral and cellular immune response to inactivated hepatitis A vaccine was investigated dynamically in a time elapse study over 1 year. Fourty-five…”
Get full text

Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately by Saenger, R., Maechler, G., Potreck, M., Zepp, F., Knuf, M., Habermehl, P., Schuerman, L.

“…The safety and reactogenicity of a booster dose of GSK Biologicals’ hexavalent DTPa-HBV-IPV/Hib vaccine ( N = 4725) was compared with the separate…”
Get full text

Identification of a novel compound heterozygote SCO2 mutation in cytochrome c oxidase deficient fatal infantile cardioencephalomyopathy by Knuf, M, Faber, J, Huth, R G, Freisinger, P, Zepp, F, Kampmann, C

“…Fatal infantile cardioencephalomyopathy (OMIM No. 604377) is a disorder of the mitochondrial respiratory chain and is characterised by neonatal progressive…”
Get full text

Vaccinations by Berner, R, Zepp, F

Get full text